GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice

GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice

Takashi Nakamura, Hitomi Tanimoto, Masayuki Okamoto, Mitsuaki Takeuchi, Yoshiharu Tsubamoto, Hitoshi Noda Biological Research Group Drug Discovery Laboratories, Sanwa Kagaku Kenkyusho, Mie, JapanCorrespondence: Takashi NakamuraSanwa Kagaku Kenkyusho, Biological Research Group Drug Discovery Laborato...

Full description

Bibliographic Details
Main Authors: Nakamura T, Tanimoto H, Okamoto M, Takeuchi M, Tsubamoto Y, Noda H
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
gip，gip receptor antagonist
anti-obesity
lipase activity
lipid metabolism
Online Access:https://www.dovepress.com/gip-receptor-antagonist-skl-14959-indicated-alteration-of-the-lipids-m-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/gip-receptor-antagonist-skl-14959-indicated-alteration-of-the-lipids-m-peer-reviewed-article-DMSO

Similar Items